SIMULTANEOUS SUBMISSIONS POLICY

The Journal of Precision Medicine and Health Research (JPMHR) strictly prohibits simultaneous or duplicate submissions in order to uphold the integrity of scholarly publishing, protect the efficiency and fairness of peer review, and avoid redundant publication. By submitting to JPMHR, authors confirm that the manuscript is not under consideration for publication elsewhere, in whole or in part, and that the work has not been submitted concurrently to another journal, conference proceedings venue that conducts journal-style review, or any other formal publication outlet that would create duplication in editorial evaluation.

This policy is intended to prevent waste of reviewer and editorial resources, reduce the risk of conflicting copyright or licensing arrangements, and protect the scholarly record from duplicate or fragmented publication that can distort indexing and evidence synthesis.

Investigation and Action

If the editorial office becomes aware of a possible simultaneous or duplicate submission, manuscript processing may be paused while the journal conducts an assessment consistent with recognized publication ethics procedures. The journal may request clarification and supporting information from the author(s), including submission timelines, correspondence with other venues, and explanations regarding any overlap with related manuscripts. If simultaneous submission is confirmed, the manuscript will be rejected without further review because the submission would be in breach of journal policy. Where violations are serious, intentional, or repeated, JPMHR may take additional actions proportionate to the misconduct, which may include temporary restrictions on future submissions for a defined period and, where necessary, notification to relevant institutions or oversight bodies when the integrity implications are significant.

Author Responsibility

Authors are responsible for ensuring that all submissions to JPMHR comply with this prohibition and for proactively disclosing relationships between manuscripts that could create overlap concerns. Authors are strongly advised to disclose any related submissions, overlapping manuscripts, and closely linked outputs that may be under consideration elsewhere, as well as relevant prior dissemination such as preprints and conference abstracts or presentations. Failure to disclose material overlap or related submissions may trigger an ethics review and may lead to rejection or other corrective action, even when the overlap is discovered after initial evaluation has begun.

Contact

Questions regarding this policy, including whether a particular prior dissemination or related submission may create eligibility concerns, may be directed to the editorial office at editor@jpmhr.com.